Singhal Priya's Form 4 filing
Biogen Inc. (BIIB) · filed Sep 5, 2024
- Accession no.
- 0001127602-24-023505
- Filed
- Sep 5, 2024
- Trade date
- Aug 30-Sep 3, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $88.0K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Singhal PriyaCIK 0001769608 | Officer (Head of Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 | Common Stock | MOption exerciseAcquired | +1,668 | $0.00 | $0 | 6,554.48 | Direct | |
| Aug 30, 2024 | Common Stock | FTax withholdingDisposed | −807 | $204.76 | −$165,241.32 | 5,747.48 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −431 | $204.22 | −$88,018.82 | 5,316.48 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 | Common Stock | MOption exerciseDisposed | −1,668 | $0.00 | $0 | 1,669 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.